Status:
UNKNOWN
Effectiveness and Safety of Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients
Lead Sponsor:
Ahmad Jabir Rahyussalim
Conditions:
Degenerative Disc Disease
Low Back Pain
Eligibility:
All Genders
20-65 years
Phase:
PHASE2
Brief Summary
This study evaluates the effectivity and safety of MSC implantation on Degenerative Disc Disease Patients by assessing visual analog scale, ROM improvement and MRI examination.
Detailed Description
The team plan to conduct research to look at the effectiveness and safety of mesenchymal stem cell implantation therapy in intervertebral disc degeneration patients. The use of allogenic mesenchymal ...
Eligibility Criteria
Inclusion
- Patients enrolled in Cipto Mangunkusumo Hospital with degenerative disc disease with no promising result after conventional treatment.
- No history of metabolic, autoimun and genetic disease(s).
- No active infection (HbsAg, HIV, CMV, Rubella).
- Agree to participate the study by signing informed consent form.
Exclusion
- Patients under 20 years old.
- Declined to participate in the study.
Key Trial Info
Start Date :
July 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04499105
Start Date
July 24 2017
End Date
December 1 2020
Last Update
August 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cipto Mangunkusumo Hospital
Jakarta Pusat, DKI Jakarta, Indonesia, 10430